SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-020662
Filing Date
2024-05-20
Accepted
2024-05-20 16:01:42
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1081269
2 ex31-1.htm EX-31.1 17094
3 ex31-2.htm EX-31.2 17106
4 ex32-1.htm EX-32.1 7786
5 ex32-2.htm EX-32.2 7830
6 logo_001.jpg GRAPHIC 57272
  Complete submission text file 0001493152-24-020662.txt   5927496

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE orgs-20240331.xsd EX-101.SCH 49251
8 XBRL CALCULATION FILE orgs-20240331_cal.xml EX-101.CAL 75607
9 XBRL DEFINITION FILE orgs-20240331_def.xml EX-101.DEF 210297
10 XBRL LABEL FILE orgs-20240331_lab.xml EX-101.LAB 382863
11 XBRL PRESENTATION FILE orgs-20240331_pre.xml EX-101.PRE 291519
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 863949
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38416 | Film No.: 24964302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)